Dexamethasone, Flurbiprofen Axetil and Delirium After Lung Cancer Surgery (NCT03200600) | Clinical Trial Compass
TerminatedPhase 4
Dexamethasone, Flurbiprofen Axetil and Delirium After Lung Cancer Surgery
Stopped: Protocol violation occurred frequently during the postoperative period.
China126 participantsStarted 2017-08-02
Plain-language summary
Delirium is a common complication in elderly patients after surgery. And its occurrence is associated with worse outcomes. The causes of delirium are multifactorial but may include pain, stress response and inflammation. Dexamethasone is commonly used to prevent the occurrence of postoperative nausea and vomiting. In a randomized controlled trial, small-dose dexamethasone (8 mg) administered before anesthesia induction improved the quality of recovery in patients after cardiac surgery. Flurbiprofen axetil is commonly used to improve postoperative analgesia while decreasing the requirement of opioids. In a randomized trial of the investigators, combined use of flurbiprofen axetil with sufentanil for postoperative analgesia reduced delirium in elderly patients after orthopedic surgery. The purpose of this 2 plus 2 factorial randomized controlled trial is to test the hypothesis that combined use of dexamethasone and flurbiprofen axetil may reduce delirium in elderly patients after lung cancer surgery.
Who can participate
Age range18 Years – 85 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Age from 18 to 85 years old;
✓. Diagnose as non-small-cell lung cancer (stage IA-IIIA);
✓. Plan to undergo surgical resection;
✓. Provide written informed consents.
Exclusion criteria
✕. Clinical evidences suggest remote metastasis of the primary cancer; have received radiotherapy, chemotherapy or targeted therapy before surgery; have received previous surgery for lung cancer; diagnosed with other cancer (other than lung cancer) currently or previously;
✕. History of therapy with glucocorticoids or immunosuppressants within 1 year, or therapy with non-steroidal anti-inflammatory drugs (NSAIDs) within 1 month;
✕. Allergy to glucocorticoids or NSAIDs;
✕. Contraindications to dexamethasone or flurbiprofen axetil, such as asthma or hives urticaria induced by aspirin or other NSAIDs; active digestive tract ulcer or bleeding, or history of repeated digestive tract ulcer or bleeding; coagulopathy (platelet count \< 50\*10\^9/L, International Normalized Ratio \> 1.4, or activated partial thromboplastin time \> 4 seconds above upper limit); current therapy with lomefloxacin, norfloxacin, or enoxacin; severe cardiac dysfunction (New York heart association class 3 or above, or Left Ventricular Ejection Fraction less than 30%) or myocardial infarction within 3 months; liver injury (transaminase higher than 2 times of upper limit); kidney injury (creatinine higher than 1.5 times of upper limit); uncontrolled severe hypertension before surgery (\> 180/120 mmHg);
What they're measuring
1
Incidence of delirium during the first five postoperative days.
Timeframe: From postoperative day 1 to postoperative day 5.